Photographs of Metro NY AWIS symposium held at Hunter College on June 22, 2002 on 
BIOTECHNOLOGY:CAREER OF THE FUTURE (with the generous support of
The New York Biotechnology  Association,
Metro Women Chemists Topical Group (NY and NJ sections of the American Chemical Society),
Hunter College Gender Equity Project (funded in part by the NSF)

Moderator Tina Lopingo and speakers Wen Zhang, Dong Liu, Shari Dermer,    
Shula Sarner and Rosemary Polsky-Newman. (see below for speaker info)




Tina Lopingco, Metro NY AWIS, NYBA

Shula Sarner, Ph.D.
Research Scientist, Acorda Therapeutics
Shula recently joined Acorda Therapeutics after her post-doctoral training at the Mount Sinai School of Medicine where she worked on Alzheimer’s disease. Prior to Sinai, she was a post-doc in the Anatomy Department of Humboldt University Medical School in Germany. Shula received her Ph.D. at the Institute of Neurology in London.

Wen Zhang, M.D., Ph.D.
Scientist, Regeneron Pharmaceuticals
Wen joined the Bioinformatics Department of Regeneron in February of 2001 after completing a post-doc at the Institute of Computational Biology at Mt. Sinai. She also received her Ph.D. in the Department of Molecular Biology from Mt. Sinai in 2000. Wen received her medical degree from
China.

Dong Liu, M.D., Ph.D.
Research Scientist, Psychogenics
Dong joined Psychogenics in 2001 after post-doctoral work at the University of Toronto. Earlier in the year he received a Ph.D. in Neurology and Neurosurgery from McGill University. He also received an M.D. in 1995  from the China Medical University and was a visiting scientist at the University of South Dakota.

Shari Dermer, Ph.D.
Senior Research Scientist,
OSI Pharmaceuticals
Shari works in the Cancer Biology Group at OSI Pharmaceuticals, which she joined as a Project Team Leader in 1996. Prior to OSI, she was a Post-doc at the Division of Molecular Medicine at Cornell University Medical College. Shari received her Ph.D. from Mount Sinai.

Rosemary Polsky-Newman, Ph.D.
Director of Corporate Development,
Exergen Biosciences
Rosemary recently joined Exergen after a successful tenure as the Director of Technology and Business Development at the New York Biotechnology Association. Prior to NYBA, she worked in various small biotech companies where she rose up the ranks from senior scientist to Director of Research. She then joined management as the Director of Corporate Planning. Rosemary did post-docs at Brandeis University and the New England Medical Center. She received her Ph.D. at Tufts University Graduate School.